Continued Weight Loss and Sarcopenia Predict Poor Outcomes in Locally Advanced Pancreatic Cancer Treated with Chemoradiation
<i>Background</i>: Surgical resection offers the best chance of survival in patients with pancreatic cancer, but those with locally advanced disease (LAPC) are usually not surgical candidates. This cohort often receives either neoadjuvant chemotherapy or chemoradiation (CRT), but uninten...
Main Authors: | Patrick Naumann, Jonathan Eberlein, Benjamin Farnia, Thilo Hackert, Jürgen Debus, Stephanie E. Combs |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-05-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/5/709 |
Similar Items
-
Cachectic Body Composition and Inflammatory Markers Portend a Poor Prognosis in Patients with Locally Advanced Pancreatic Cancer Treated with Chemoradiation
by: Patrick Naumann, et al.
Published: (2019-10-01) -
Editorial: Systemic markers of muscle loss
by: Amanda Soares Santos, et al.
Published: (2023-06-01) -
Shared and Divergent Epigenetic Mechanisms in Cachexia and Sarcopenia
by: Laura Yedigaryan, et al.
Published: (2022-07-01) -
Recent developments in the field of cachexia, sarcopenia, and muscle wasting: highlights from the 11th Cachexia Conference
by: Nicole Ebner, et al.
Published: (2019-02-01) -
Optimization of a mouse model of pancreatic cancer to simulate the human phenotypes of metastasis and cachexia
by: Victoria Spadafora, et al.
Published: (2024-04-01)